| Literature DB >> 29030480 |
Maria S Ioannou1, Gopinath Kulasekaran2, Maryam Fotouhi2, Justin J Morein2, Chanshuai Han2, Sarah Tse2, Nadya Nossova2, Tony Han2, Erin Mannard2, Peter S McPherson1.
Abstract
Epidermal growth factor (EGF) activates the EGF receptor (EGFR) and stimulates its internalization and trafficking to lysosomes for degradation. However, a percentage of EGFR undergoes ligand-independent endocytosis and is rapidly recycled back to the plasma membrane. Importantly, alterations in EGFR recycling are a common hallmark of cancer, and yet, our understanding of the machineries controlling the fate of endocytosed EGFR is incomplete. Intersectin-s is a multi-domain adaptor protein that is required for internalization of EGFR Here, we discover that intersectin-s binds DENND2B, a guanine nucleotide exchange factor for the exocytic GTPase Rab13, and this interaction promotes recycling of ligand-free EGFR to the cell surface. Intriguingly, upon EGF treatment, DENND2B is phosphorylated by protein kinase D and dissociates from intersectin-s, allowing for receptor targeting to degradation. Our study thus reveals a novel mechanism controlling the fate of internalized EGFR with important implications for cancer.Entities:
Keywords: DENN domain; endocytosis; exocytosis; growth signalling; intersectin‐s
Mesh:
Substances:
Year: 2017 PMID: 29030480 PMCID: PMC5709770 DOI: 10.15252/embr.201744034
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807